We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Firm To High Court: Confidential Patent Agreement Didn’t Affect On-Sale Date

Mealey's (August 27, 2018, 4:03 PM EDT) -- WASHINGTON, D.C. — The existence of confidential licensing and purchase agreements with an investor did not result its pharmaceutical invention being “otherwise available to the public,” per the Leahy-Smith America Invents...
To view the full article, register now.